Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study.
Cancer Invest
; 35(4): 248-255, 2017 Apr 21.
Article
in En
| MEDLINE
| ID: mdl-28333566
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hemoglobins
/
Carcinoma, Renal Cell
/
Biomarkers, Tumor
/
Protein Kinase Inhibitors
/
Kidney Neoplasms
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer Invest
Year:
2017
Document type:
Article
Affiliation country:
Country of publication: